B.C. Reg. 103/2023: Drug Schedules (Limits on Sale) Regulation
Made under the Pharmacy Operations and Drug Scheduling Act
How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →
Get alerted when the next rule lands
New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.
Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.
The rule, in full
122 words as published, April 26, 2023. View the original →
B.C. Reg. 103/2023, deposited April 18, 2023, under the PHARMACY OPERATIONS AND DRUG SCHEDULING ACT [section 23 (4)]. Ministerial Order M109/2023, dated April 17, 2023. I, Adrian Dix, Minister of Health, order that the attached Drug Schedules (Limits on Sale) Regulation is made. — A. DIX, Minister of Health.
DRUG SCHEDULES (LIMITS ON SALE) REGULATION
Limits on sale
1 A drug listed in the table in this section must not be sold from a pharmacy to a person unless at least one of the following conditions is met: (a) the person is a citizen or permanent resident of Canada; (b) the drug is sold directly to the person, while the person is on the premises of the pharmacy. Drug Semaglutide
Documents
- The text in The British Columbia Gazette · April 26, 2023